The Future of Digital Therapeutics: Evidence-based Treatment From Your Smartphone
The digital therapeutics (DTx) industry represents the unique intersection of digital health, mhealth, remote patient monitoring and pharmaceuticals. Digital therapeutics are evidence-based interventions that are clinically validated by the Food and Drug Administration (FDA) and can be prescribed by providers as standalone treatments or complements to traditional drug therapy. The first software-only therapeutic was approved by the FDA in November 2018, and with over 100 DTx vendors operating in this space, this market is poised to take off in the next few years. This 30-minute webinar will help both IT and non IT leaders understand this nascent industry and prepare to leverage DTx products.
Things You’ll Learn:
- A summary of the global digital therapeutics market
- Unique opportunities and challenges for digital therapeutics
- How health systems can prepare to prescribe these products